Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2014.07.10
北京市中伦（深圳）律师事务所关于公司实施员工持股计划的法律意见书
2014.07.10
关于公司股票复牌的公告
2014.07.10
第三届监事会第二次会议决议公告
2014.07.10
第三届董事会第二次会议决议公告
2014.07.10
员工持股计划（草案）摘要
2014.07.10
国联汇金29号集合资产管理计划资产管理合同
2014.07.08
关于公司股票临时停牌的公告
2014.05.30
2013年年度权益分派实施公告
2014.05.17
2013年度股东大会的法律意见书
2014.05.17
2013年度股东大会决议公告
第一页
上一页
112
113
114
115
116
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
